Abstract Material remains of ancestor nucleotides and proteins are largely unavailable, thus sequence comparison among homologous genes in present-day organisms forms the core of current knowledge of molecular evolution. Variation in protein three-dimensional structure is a basis for functional diversity. To study the evolution of threedimensional structures in related proteins would significantly improve our understanding of protein evolution and function. A protein may contain ancestor conformations that have been allosterically suppressed by evolutionarily additive structures. Using monoclonal antibody probes to detect such conformation in proteins after removing the suppressor structure, our study demonstrates three-dimensional structure evidence for the evolutionary relationship between troponin I and troponin T, two subunits of the troponin complex in the Ca 2? -regulatory system of striated muscle, and among their muscle type-specific isoforms. The experimental data show the feasibility of detecting evolutionarily suppressed history-telling structural states in proteins by removing conformational modulator segments added during evolution. In addition to identifying structural modifications that were critical to the emergence of diverged proteins, investigating this novel mode of evolution will help us to understand the origin and functional potential of protein structures.
Introduction
The study of evolution depends crucially on fossil materials. However, material remains of ancestor nucleotides and proteins are largely unavailable, thus the evolutionary relationship between proteins is evaluated by sequence comparisons. Sequence alignment among homologous genes in present-day species is the primary method in current molecular evolution studies and has provided powerful information for how evolution has worked (Benner et al. 2002) . Nonetheless, the functional evolution of a protein is determined by changes in three-dimensional structures. To further investigate how the three-dimensional structure of a protein has evolved would significantly strengthen the evolutionary relationships indicated by nucleotide and amino acid sequence comparisons. In addition, protein three-dimensional structures may contain allosteric information that reflects the evolutionary past. The small size of the current database of high-resolution three-dimensional structures, especially allosteric states, determined by X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy is insufficient to lead the study of molecular evolution. Higher-throughput approaches to detect homologous three-dimensional structures for their evolutionary relationships are needed to compensate for the limitations of sequence analysis and structural biology data (Blundell et al. 2006) .
The binding affinity of an antibody to an antigen depends on three-dimensional structure fits between the antibody variable region (the paratope) and the epitope on the antigen protein (Fig. 1a) . Immunogenic epitopes are often variable structures and it is established that the degree of cross-reactivity of an antibody to homologous proteins reflects their structural similarity and diversity (Miller and Cohen 1991) . This ''immunological distance'' has been used to evaluate the phylogeny of homologous proteins (Li and Tanimura 1987; Kaminogawa et al. 1989; Prager 1993) . While the cross-reactivity of polyclonal antibodies reflects the overall structural similarity of related proteins, monoclonal antibodies (mAbs) (Kohler and Milstein 1975) detect similarities and differences in specific epitopic structures. Selected mAbs against conserved or evolving epitopes may be used as three-dimensional structure probes to investigate evolutionary conservation and variation. In addition to detecting a static structure, antibodies against allosteric epitopes provide probes for measuring conformational changes in a protein (Wang and Jin 1998; Jin et al. 2000a, b) . Protein epitopic structures can be quantitatively studied by microtiter plate enzyme-linked immunosorbent assay (ELISA) that effectively detects conformational differences and changes under native conditions (Wang and Jin 1998; Jin et al. 2007) .
Gene duplication and sequence divergence produce genetic variation and molecular diversity that fuel evolution (Raes and Van de Peer 2003) . Troponin I (TnI) and troponin T (TnT) are two subunits of the troponin complex that regulates the contraction of striated (skeletal and cardiac) muscles (Perry 1998 (Perry , 1999 Jin et al. 2008) . The two Fig. 1 Background information. a Antigen-antibody binding depends on the structural fit between the antigenic epitope and the antibody paratope. A change in the conformation of an antigen protein may alter the affinity of an antibody. b TnI and TnT are two subunits of the troponin complex and play interrelated functions in the thin-filament Ca 2? regulatory system of striated muscle. c Three pairs of linked TnI and TnT genes are present in vertebrates. Supporting the functional pairing of slow TnI and cardiac TnT genes, the Western blots showed that slow TnI was expressed in embryonic and neonatal hearts together with cardiac TnT. d Western blots using polyclonal anti-TnI and anti-TnT antibodies RATnI and RATnT detected multiple and distinct TnI and TnT bands in the skeletal and cardiac muscles of Atlantic hagfish (Myxine glutinosa), indicating early emergence and divergence of the TnI-TnT gene superfamily. The results were confirmed by Western blots using pan-TnI mAb 4D12 and pan-TnT mAb 2C8 (data not shown) proteins function together but distinctively in the troponin complex (Fig. 1b) and genes encoding TnI and TnT are closely linked in the vertebrate genome (Huang and Jin 1999) , suggesting their origin from the duplication of a single ancestral gene followed by neofunctionalization. As linked pairs of genes, TnI and TnT have each evolved into three isoforms with specific expressions in cardiac and slow and fast skeletal muscles (Barton et al. 1997; Tiso et al. 1997; Huang and Jin 1999; Perry 1998 Perry , 1999 Jin et al. 2008) (Fig. 1c) , implying a series of duplication events from an ancestral TnI-TnT gene pair followed by subfunctionization and neofunctionalization. The fast TnI-fast TnT gene pair shows linked expression. Although the cardiac TnI-slow TnT and slow TnI-cardiac TnT gene pairs are apparently scrambled, the slow TnI-cardiac TnT gene pair coexpresses in embryonic cardiac muscle as a functional pair (Fig. 1c) . These data suggest that the evolution of the three linked TnITnT gene pairs has a functional basis.
Distinct TnI and TnT isoforms are found in the cardiac and skeletal muscles of hagfish (Atlantic hagfish, Myxine glutinosa), an elementary vertebrate that shared with true vertebrates a common ancestor that lived some half a billion years ago (Fock and Hinssen 2002) (Fig. 1d) , indicating an early emergence of TnI and TnT and their isoform genes. This long-existing TnI-TnT gene family encoding genetically and functionally close-linked allosteric protein isoforms provides an excellent system to experimentally study the evolution of protein threedimensional structures. Using a collection of antibody probes to compare epitope structures and detect evolutionarily suppressed molecular conformation after removing a suppressor structure, the present study demonstrated three-dimensional structure evidence for the evolutionary relationships between TnI and TnT and among their muscle type-specific isoforms. The experimental data showed the feasibility of detecting suppressed history-telling structural states in proteins by removing conformational modulator segments added during evolution, suggesting a novel mode of protein evolution.
Materials and Methods

Analysis of Nucleotide and Amino Acid Sequences
Amino acid sequences of TnI and TnT were aligned with the Clustal W 2.0.10 computer program (Larkin et al. 2007 ) and a phylogenetic tree was built with the Geneious 4.5.3 program using the Jukes-Cantor genetic distance model and neighbor-joining tree building method (Drummond et al. 2008) . The arbitrary random seed was 562,379 at 100 samples, creating a consensus tree with a support threshold percentage of 50.
The GenBank accession numbers for the protein and nucleic acid sequences are human fast TnI (NM_003282), human slow TnI (BC012600), and human cardiac TnI (NM_000363); mouse fast TnI (NM_009405), mouse slow TnI (NM_021467), and mouse cardiac TnI (NM_009406); chicken fast TnI (NM_205417), chicken slow TnI (XM_419242), and chicken cardiac TnI (NM_213570); Xenopus laevis fast TnI (AF480427), Xenopus tropicalis slow TnI (AAH61268.1), and Xenopus tropicalis cardiac TnI (NM_001011410); zebrafish fast TnI (AF425744), zebrafish slow TnI (CAD59124.1), and zebrafish cardiac TnI (XM_686456); human fast TnT (NM_001042782), human cardiac TnT (NM_001001430) and human slow TnT (S69208); mouse fast TnT (L49467), mouse cardiac TnT (L47549), and mouse slow TnT (AF020946); chicken fast TnT (M22158), chicken cardiac TnT (NM_205449), and chicken slow TnT (NM_205114); Xenopus laevis fast TnT (AY114144), Xenopus laevis cardiac TnT (AF467920), and toad slow TnT (AY773671); and Salmo salar fast TnT (AF072687), zebrafish cardiac TnT (XM_685694), and zebrafish slow TnT (NM_181499).
Protein Engineering, Expression, and Purification cDNAs encoding TnI and TnT isoforms were cloned into the T7 RNA polymerase-based pAED4 plasmid vector (Jin 1995) for protein expression in E. coli. Modified cDNAs encoding TnI and TnT fragments (Fig. 2) were constructed using polymerase chain reaction (PCR) as previously described, in which forward and reverse primers were designed to contain an ATG codon prior to the N-terminal deletion site or a stop codon at the C-terminal deletion site (Biesiadecki et al. 2007 ). The PCR-amplified cDNA fragments were restriction enzyme modified at the ends and cloned into the pAED4 expression vector. The recombinant plasmid was verified by DNA sequencing. The deletion constructs as well as intact TnI and TnT were expressed in BL21(DE3)pLysS E. coli as nonfusion proteins and purified as described Biesiadecki et al. 2004 Biesiadecki et al. , 2007 .
Anti-TnI and Anti-TnT Antibodies An anti-TnI polyclonal antiserum RATnI was raised by immunization of a New Zealand White rabbit with purified chicken breast muscle fast TnI (Jin 1996 ).
An anti-TnT polyclonal antiserum RATnT was raised by immunization of a New Zealand White rabbit with purified chicken adult breast muscle fast TnT (Wang and Jin 1998) .
A mouse mAb TnI-1 was developed by immunization with purified chicken breast muscle fast TnI . A mouse mAb 4D12 was developed by immunization with purified N-terminal truncated mouse cardiac TnI (Barbato et al. 2005) . On TnI fragments expressed in E. coli, the Western blots in Fig. 2a demonstrate the specificity of mAbs TnI-1 and 4D12 against C-terminal epitopes.
A mouse mAb T12 (provided by Professor Jim Lin, University of Iowa) was generated by immunization with purified rabbit fast skeletal muscle TnT (Lin et al. 1984) . Western blots on TnT fragments revealed its specificity against an epitope in the middle region of the TnT polypeptide (Fig. 2b) .
A mouse mAb 1G9 was developed by immunization with purified human cardiac TnT as described previously (Wang and Jin 1998) . The Western blots on TnT fragments in Fig. 2b showed its specificity against an epitope in the C-terminal T2 region.
A mouse mAb 4H6 was developed by immunization with a purified middle-region fragment of mouse cardiac TnI (Du et al. 2008) . A mouse mAb CT3 recognizing cardiac TnT and slow TnT was generated by immunization with purified bovine cardiac TnT (Jin et al. 2000a) . A mouse mAb 2C8 recognizing a conserved stable epitope with similar affinities among all three TnT isoforms in the vertebrates was developed by immunization with purified human cardiac TnT (Jin et al. 2003; Zhang et al. 2006) .
Despite the notion that antisera produced in vivo are adapted to a non-self-recognizing rule, numerous studies, including our development of multiple mAbs against troponin subunits including 4D12 and 4H6 shown in the present study, have demonstrated that mAbs generated by hybridoma technology can strongly cross-react to Fig. 2 TnI and TnT constructs and site-specific mAbs. Intact TnI and TnT and their fragments were prepared to map the location of epitopes recognized by the mAbs used in our study and for conformational analysis. a Mouse cardiac TnI fragments were constructed with a deletion of the cardiac TnI-specific N-terminal 28 amino acids (cTnI-ND) or deletions of the N-terminal 28 amino acids and the C-terminal 19 amino acids (cTnI-ND-CD). Western blots showed that mAb 4H6 recognizes both fragments as well as intact cardiac TnI, indicating specificity to a middle epitope. In contrast, mAbs TnI-1 and 4D12 recognize intact cardiac TnI and cTnI-ND but not cTnI-ND-CD, indicating specificity to the C-terminus. b Mouse cardiac, fast TnT, and slow TnT fragments with N-terminal deletions were constructed by selective deletion of the Nterminal variable region (TnT-ND), or extended deletion into the conserved middle region (cardiac TnT-ND 92 and cardiac TnT-ND 130 ), or deletion of both the N-terminal and the middle regions (TnT-T2 [Heeley et al. 1987] ). The Western blot analysis localized the epitopes of mAbs 2C8, T12, and 1G9 in the middle or C-terminal regions of the TnT polypeptide J Mol Evol (2009) 68:448-460 451 homologous antigens from the host species, i.e., the mouse, in which the immunization was carried out. This epitopiclevel cross-reactivity allows an inclusion of the host species in the study of phylogenetic relationship of a protein using mAbs as three-dimensional structure probes.
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Western Blotting
Muscle tissues were homogenized in Laemmli SDS-PAGE sample buffer (containing 2% SDS, which prevents protein degradation) using a high-speed mechanical homogenizer.
The muscle homogenates and SDS-PAGE samples of purified TnI, TnT, and the engineered protein fragments were resolved by Laemmli or Tris-Tricine gel electrophoresis (Jin 1995) . The gels were stained with Coomassie Brilliant Blue R250 to reveal the protein bands. Duplicate gels were electrically blotted to nitrocellulose or PVDF membranes. After blocking in Tris-buffered saline (TBS) containing 0.5% Triton X-100, 0.05% SDS, and 1% bovine serum albumin (BSA), the membranes were incubated with an anti-TnI or anti-TnT antibody in TBS containing 0.1% BSA, washed using TBS containing 0.5% Triton X-100 and 0.05% SDS, incubated with alkaline phosphataseconjugated anti-rabbit IgG or anti-mouse IgG second antibody (Sigma Co., St. Louis, MO), washed again, and processed for colorimetric development in 5-bromo-4-chloro-3-indolylphosphate-nitro blue tetrazolium substrate solution, as described previously (Wang and Jin 1998) .
ELISA Epitope Analysis
ELISA epitope analysis (Wang and Jin 1998; Jin et al. 2007 ) was employed to compare the relative binding affinity of the antibody epitope probes to the isoforms and fragments of TnI and TnT for their relationships in threedimensional structure. The purified TnI or TnT protein was dissolved in Buffer A (0.1 M KCl, 3 mM MgCl 2 , 10 mM PIPES, pH 7.0) at 2 lg/ml and used at 100 ll/well to noncovalently coat 96-well microtiter plates by incubation at 4°C overnight. Bovine serum albumin-coated wells were set as background controls. After removing unbound proteins and blocking any remaining free plastic surface by washing three times with Buffer A containing 0.05% Tween-20 (Buffer T), the immobilized TnI or TnT was incubated with 100 ll/well serial dilutions of anti-TnI or anti-TnT first antibody in Buffer T containing 0.1% BSA at room temperature for 2 h. Following three washes with Buffer T to remove the unbound first antibody, the plates were incubated with 100 ll/well horseradish peroxidaseconjugated anti-mouse or anti-rabbit immunoglobulin second antibody (Sigma Co.) in Buffer T containing 0.1% BSA at room temperature for 1 h. The plates were washed three times as above to remove unbound second antibody before the addition of H 2 O 2 /2,2 0 -azinobis-(3-ethylbenzthiazolinesulfonic acid) substrate solution (100 ll/ well). The enzymatic color reaction in each assay well was monitored for A 405 nm vs. A 655 nm at a series of time points using an automated microplate reader (BioRad Benchmark, Hercules, CA). The values in the linear course of the color development were used to plot titration curves for comparing the relative binding affinity of the antibodies to various TnI or TnT constructs. Antibody dilutions at 50% maximum binding were calculated from the titration curves to compare the relative binding affinity. The experiments were done in triplicate and repeated one or more times. Statistical analysis was performed using Student's t-test. All values are presented as mean ± SD.
Results
Phylogeny of TnI and TnT Isoforms Deduced from Sequence Analysis
Although TnI and TnT are significantly diverged proteins, the close genomic linkage of TnI and TnT genes and their shared feature of variable N-terminal region suggest the origination of TnI and TnT by duplication of an ancestor gene. Supporting this hypothesis, phylogenetic analysis of amino acid sequences showed a distant homology between the TnI and the TnT gene families (Fig. 3) , consistent with their placement in the same sequence family (PF00992) in the Pfam database (http://pfam.janelia.org/; Mistry and Finn 2007; Finn et al. 2008) .
Sequence analysis of the muscle fiber type isoforms of TnI and TnT further demonstrated that the divergence of the three muscle type-specific isoforms is greater than the divergence of each isoform in different species (Fig. 3) , consistent with the previous data from analysis of mammalian and avian TnT isoforms . Although a [fast skeletal (slow skeletal, cardiac)] evolutionary relationship was indicated by a previous sequence-based study of other muscle proteins (Oota and Saitou 1999) , this order of divergence was unclear from the sequence analysis of the muscle type-specific TnI and TnT isoforms.
Unidirectional Immunological Cross-Reactivity of Polyclonal Anti-TnI and Anti-TnT Antibodies To investigate whether the distant relationship between TnI and TnT genes suggested by sequence analysis can be detected in similarities of folded protein structure, we first tested the cross-reactivity of an anti-TnI polyclonal antiserum with TnT and that of an anti-TnT polyclonal antiserum with TnI for overall similarity between epitopic structures of the two proteins. The Western blots in Fig. 4a show that antiserum RATnI, raised by chicken fast TnI immunization, cross-reacted with mouse fast TnT but not cardiac TnT or slow TnT. RATnI did not show detectable cross-reaction with chicken fast TnT in the Western blots. The nonreactivity of RATnI with chicken fast TnT excludes the possibility of TnT contamination in the chicken fast TnI immunogen used in generating the RATnI antiserum. Therefore, the cross-reactivity of RATnI with TnT indicates the presence of TnI-like epitope structures in TnT inherited from a common ancestor. This result also supports the notion that TnI and TnT genes were evolved by duplication, other than splitting, of an ancestor gene followed by neofunctionalization.
Interestingly, the polyclonal antiserum RATnT raised by fast TnT immunization did not show detectable crossreactivity with TnI (Fig. 4a) . This unidirectional immunological cross-reactivity between TnI and TnT indicates that the dominant immunogenic epitopes in the TnT immunogen are not present in TnI, suggesting evolutionarily diverged structures that were absent in the common ancestor of TnI and TnT. The RATnI and RATnT antibodies produced with identical immunization procedures exhibited similar overall avidities, indicating comparable immunogenecities of TnT and TnI. Therefore, it is less likely that the dominant immunogenic epitopes in presentday TnT had existed in the common ancestor but could have been lost in present-day TnI to allow weaker immunogenic epitopes to be effective.
Troponin I is the inhibitory subunit of troponin complex whose primary function is as an inhibitor of actin-myosin interactions (Perry 1999) . Consistent with this conserved function, the presence of a TnI-like epitope structure in present-day TnI and TnT further suggested the hypothesis that the ancestor of TnI and TnT was likely a TnI-like inhibitory protein.
The result that RATnI discriminantly cross-reacts with fast TnT rather than cardiac or slow TnT (Fig. 4a) indicates a shorter immunological distance to fast TnI from fast TnT than from cardiac or slow TnT, suggesting the further hypothesis that the original TnI-TnT gene pair evolved by duplication of the ancestral troponin gene was a fast TnITnT-like pair and the present-day fast TnI and fast TnT genes had less neofunctionalization from the original gene pair compared to the other two TnI-TnT gene pairs.
Detection of Evolutionarily Suppressed TnI-Like Epitope Structures in TnT
To further investigate the above hypotheses beyond static immunological distance, we tested the feasibility of detecting ancestor-like three-dimensional structure states that are suppressed in the evolutionarily diverged presentday protein. The N-terminal variable region of TnT is an evolutionarily additive structure (Jin and Samanez 2001) that conveys conformational and functional modulations (Wang and Jin 1998; Jin and Root 2000; Biesiadecki et al. 2007 ). Therefore, we made N-terminal truncated TnT (Fig. 2b) to examine the effect of removing this evolutionary addition on the three-dimensional structure of the conserved regions of TnT.
The Western blots in Fig. 4b showed no detectable crossreaction between polyclonal antiserum RATnI and intact cardiac TnT. However, deletion of the N-terminal region of cardiac TnT resulted in significant binding of RATnI, indicating an unsuppression of TnI-like (ancestor-like) three-dimensional structures. Epitope structures detected by Western blotting have gone through denaturation-renaturation that may affect the folding states. Therefore, we verified the detection of evolutionarily suppressed TnI-like threedimensional structures in cardiac TnT by ELISA affinity titration under native conditions. The results in Fig. 4b confirmed that deletion of the N-terminal domain of cardiac TnT significantly increased the binding affinity of RATnI.
The C-terminal region of TnI is evolutionarily conserved among isoforms and across species . We employed mAb TnI-1 against a highly conserved Cterminal epitope of TnI as a probe for ancestor-like threedimensional structure to further demonstrate the detection of evolutionarily suppressed TnI-like three-dimensional structure inherited in TnT. Consistent with the result Fig. 4 Detection of TnI-like epitope structures in TnT. a Western blots showed that polyclonal antibody RATnI raised by immunization with chicken fast skeletal muscle TnI cross-reacts with mouse fast TnT but not slow TnT and cardiac TnT, which are identified by the anti-cardiac TnT/slow TnT mAb CT3. In contrast, polyclonal antibody RATnT raised using chicken fast skeletal muscle TnT immunization does not have detectable cross-reaction with TnI. The presence of TnI-like epitopic structures in TnT, but not vice versa, indicates inheritances from a TnI-like ancestor. b Western blot and ELISA affinity titration curves showed that while intact cardiac TnT was not recognized by RATnI, removal of the N-terminal domain significantly increased the affinity to RATnI as shown by the significantly lowered antibody concentration (the higher fold of dilution) to reach 50% maximum binding (from [2 9 10 -3 to 6.40 ± 0.36 9 10 -4 ; **p \ 0.001). The detection of a TnI-like epitope conformation in cardiac TnT after deletion of the N-terminal region was further demonstrated by Western blotting and ELISA using mAb TnI-1 raised against the conserved C-terminal domain of TnI (antibody dilutions for 50% maximum binding increased from [1 9 10 -3 to 9.93 ± 4.41 9 10 -6 ; **p \ 0.001). A cardiac TnT fragment slightly smaller than cTnT-ND produced as a side product during bacterial expression and purification (the very light band in the SDS gel) showed even stronger binding to mAb TnI-1 (indicated in the Western blot by an asterisk), suggesting a further unsuppressed molecular conformation obtained using polyclonal antibody RATnI, the Western blot and ELISA titration curves in Fig. 4b showed a significant cross-reaction of TnI-1 with N-terminal truncated, but not intact, cardiac TnT.
These experiments demonstrated that after the threedimensional structure of TnT evolved to become distinct from that of TnI as the lack of cross-reactivity of RATnI and TnI-1 with intact cardiac TnT, removal of the evolutionarily additive and conformationally modulating N-terminal region resulted in an ancestor-like conformation as detected by the anti-TnI antibodies. The experimental data indicate the presence of evolutionarily suppressed ancestor-like three-dimensional structures in present-day TnT, which can be detected by removing an evolutionary determinant.
Detection of an Evolutionarily Suppressed Fast TnT-Like Epitope Structure in Cardiac TnT
Since the sequence phylogeny shown in Fig. 3 did not provide clear information, we further examined the evolutionary relationship among the muscle type TnI and TnT isoforms using folded structure information and investigated epitope similarities among the three TnT isoforms. The immunological distance between fast TnT and cardiac or slow TnT was examined using ELISA affinity titration. The results showed that the polyclonal antiserum RATnT raised with fast TnT immunization cross-reacted more strongly with cardiac TnT than with slow TnT (Fig. 5a ). The Western blot in Fig. 5b further showed that mAb T12 raised with fast TnT immunization cross-reacted with cardiac TnT but not slow TnT. The result that fast TnT is related more closely to cardiac TnT than to slow TnT suggests that the fast TnI-fast TnT and slow TnI-cardiac TnT gene pairs shared a common ancestor (a fast TnI-fast TnT-like gene pair as suggested above).
This evolutionary lineage was further demonstrated by detecting suppressed fast TnT-like epitope structure in cardiac TnT after removing the evolutionarily additive N-terminal domain. The Western blot in Fig. 5b detected a much increased binding of mAb T12 to N-terminal truncated cardiac TnT in comparison to intact cardiac TnT. In contrast, N-terminal truncation of slow TnT did not produce such an effect (Fig. 5b) . The detection of an evolutionarily suppressed fast TnT-like conformational state in cardiac TnT after removing the evolutionary effect of the N-terminal domain was confirmed by ELISA affinity titration under native conditions (Fig. 5b) . It is worth noting that TnT is an elongated protein in which the N-terminal region is an extended structure (Cabral-Lilly et al. 1997; Wendt et al. 1997) . Therefore, removal of the N-terminal domain enhances antibody affinity to the distant T12 epitope structure by modulating conformation other than unmasking a static structure.
Detection of an Evolutionarily Suppressed Cardiac TnT-Like Epitope Structure in Slow TnT
To investigate whether the cardiac TnI-slow TnT gene pair had evolved from duplication of the original fast TnI-fast TnT-like gene pair or from a slow TnI-cardiac TnT-like gene pair, the fact that mAb T12 raised by fast TnT immunization cross-reacts with cardiac TnT but not slow TnT supports the latter hypothesis. To further test this hypothesis, we experimentally examined the similarity of folded structures of cardiac TnT and slow TnT. mAb 1G9 raised with cardiac TnT immunization exhibited a weak cross-reaction with slow TnT in Western blot but did not react with fast TnT (Fig. 2b) , indicating the presence of a cardiac TnT-like epitope in slow but not fast TnT.
Showing the effects of serial N-terminal truncations of slow TnT on the conformation of the 1G9 epitope in the C-terminal region (Fig. 2b) , the Western blots in Fig. 5c detected progressive increases in the affinity of 1G9 when the N-terminal and middle regions were removed. These effects were further demonstrated by ELISA affinity titrations (Fig. 5c) . The results indicate that the cardiac TnTlike 1G9 epitope structure has diverged significantly in slow TnT, but the evolutionarily suppressed three-dimensional structure could be detected more clearly when the conformational modulating effect of the N-terminal region was removed. The restoration of a cardiac TnT-like threedimensional structure in slow TnT was further demonstrated by the even higher affinity of 1G9 to the isolated C-terminal T2 domain of slow TnT, indicating its nature as a ''default'' structure (Fig. 5c) .
In contrast, removing the N-terminal and middle regions of fast TnT did not produce detectable binding of mAb 1G9 (data not shown). The absence of a 1G9 epitope structure in fast TnT suggests its emergence after the divergence of the ancestors of slow TnI-cardiac TnT and fast TnI-fast TnT gene pairs. Our unpublished observation that the majority of a large group of mAbs raised by immunization using cardiac TnT cross-react with slow TnT but not fast TnT also supports this evolutionary lineage.
Discussion
In the present study, we attempted to experimentally determine the evolutionary lineage of proteins through the analysis of folded structures. Using representative antibody epitope probes (summarized in Table 1 ) to dissect protein structure and conformational states, we experimentally determined the evolutionary lineages in the TnI-TnT gene family (Fig. 6a) . In addition to confirming that TnI and TnT are distantly related proteins as suggested by sequence analysis, the results demonstrated that TnI and TnT arose from a TnI-like ancestor protein.
We further detected inheritances in the slow TnI-cardiac TnT gene pair from the fast TnI-fast TnT-like ancestor pair and in cardiac TnI-slow TnT pair from the slow TnI-cardiac TnT-like ancestor gene pair. This pattern is consistent with the [fast skeletal (slow skeletal, cardiac)] evolutionary relationship indicated by a previous sequence analysis of other muscle proteins (Oota and Saitou 1999) . Among the three subunits of troponin (Fig. 1b) , troponin C (TnC) is a member of the calmodulin family of Ca 2? -binding proteins. Different from TnI and TnT, which have evolved into three isoforms for the three muscle types of vertebrates, TnC is present in only two isoforms: fast TnC (Gahlmann and Kedes 1990 ) and slow-cardiac TnC (Parmaceck and Leiden 1989) . The undifferentiated utilization of the same TnC isoform in cardiac and slow skeletal muscles supports the hypothesis that the duplication of the cardiac and slow TnI-TnT gene pairs was a relatively recent event.
The retention and evolution of TnI and TnT from duplication of a common ancestor provide an excellent example of the initial role of neofunctionalization since the linked expression of the duplicated genes precludes the role of subfunctionalization. On the other hand, the later duplication and retention of the muscle type-specific TnITnT gene pairs represent typical subfunctionalizations (Li et al. 2005) .
Beyond the static-state immunological distance, the effect of removing an evolutionarily additive structure from TnT on the detection of evolutionarily suppressed TnI-like Fig. 5 Epitope mapping of the evolutionary lineage of TnT isoforms. a ELISA affinity titration curves showed that polyclonal antiserum RATnT raised against fast TnT cross-reacts with cardiac TnT more strongly than with slow TnT (antibody dilutions for 50% maximum binding were 2.90 ± 0.10 9 10 -4 and 3.00 ± 0.69 9 10 -3
, respectively; *p \ 0.01), indicating that fast TnT is related more closely to cardiac TnT than to slow TnT. b Western blot reactivity and ELISA affinity titration curves demonstrate that mAb T12 raised against fast TnT cross-reacts with cardiac TnT (cTnT) but not slow TnT (sTnT). The affinity of T12 for cardiac TnT was significantly increased after deletion of the N-terminal variable region (antibody dilutions for 50% maximum binding increased from 2.90 ± 2.76 9 10 -4 to 1.03 ± 0.32 9 10 -5
; **p \ 0.001), demonstrating an enhanced fast TnT-like epitope structure. c Western blots and ELISA affinity titration curves demonstrate that mAb 1G9 that was raised against cardiac TnT and cross-reacts moderately with slow TnT but not fast TnT (Fig. 2b ) exhibited a significantly increased affinity for slow TnT after deletion of the N-terminal variable region (antibody dilutions for 50% maximum binding increased from [1 9 10 -2 to 1.02 ± 0.07 9 10 -4 ; **p \ 0.001), and increased further in the isolated C-terminal T2 domain (50% maximum binding dilution = 5.47 ± 0.06 9 10 -5 ; ## p \ 0.001), demonstrating an enhanced cardiac TnT-like epitope structure epitopic structures inherited from the TnI-like ancestor is consistent with the role of the N-terminal variable region of TnT as a conformational modulator (Wang and Jin 1998; Jin and Root 2000; Biesiadecki et al. 2007) . In contrast to the commonly seen destructive effects in which deleting a portion of a protein destroys the integrity of antibody epitopes, the dissection of TnT proteins based on their structural and functional domains demonstrated threedimensional structures showing ancestor-like conformational states. This reversal effect indicates that ancestor-like structures may be retained in a suppressed state in presentday proteins and be exhibited when the evolutionary modulating determinant(s) is(are) removed. The N-terminal region of TnT is a conformational modulator and, in a broad sense, acts as a molecular switch. However, the N-terminal region of TnT does not simply act in activating and inactivating TnT function. Both intact and N-terminal truncated TnTs are active in regulating muscle contraction and TnI does not represent a different functional state of TnT. Therefore, the detection of TnI-like epitopes in TnT after removing the evolutionarily additive N-terminal modulator indicates structural changes reflecting a reversal of structural evolution to an ancestor-like state.
In addition to providing experimental evidence for the evolution of TnI, TnT, and their isoforms, the detection of ancestor-like epitopic structures in present-day proteins by removing evolutionarily additive structures has a twofold significance. First, it suggests the hypothesis that while genetic variations produce gradual changes in the amino acid sequence of proteins to provide the raw material for natural selection and molecular evolution, functional divergence and fitness value are based mainly on threedimensional structural changes that could be a global conformational change produced by critical sequence changes in a modulator domain. This model may also explain quantum functional changes and leaps in an evolutionary lineage. Our data suggest a critical role of ''evolutionary determinants'' that are new structures capable of tuning the global conformation and function during protein evolution.
Second, our findings suggest that the evolution of protein three-dimensional structure is under a selection in which a trait would be fixed and maintained depending on the final functional outcome. Therefore, present-day proteins could retain potentials of conferring ancestor-like three-dimensional structures that are suppressed by Fig. 6 Summary and hypothesis. a The evolution of TnI, TnT, and the isoform gene pairs is summarized from data on sequence analysis, immunological distance, and experimental determination of evolutionarily suppressed conformational states. This evolutionary lineage began from a TnI-like ancestor that was duplicated to form a fast TnIfast TnT-like gene pair. A later duplication event resulted in the emergences of a slow TnI-cardiac TnT-like gene pair that was further duplicated to form the present-day slow TnI-cardiac TnT and cardiac TnI-slow TnT gene pairs. b A hypothesis is proposed to suggest that the evolution of a protein three-dimensional structure could result from addition and/or alteration of a critical structure that modulates the global conformation and function of the protein. Ancestor-like three-dimensional structures may be suppressed in the new protein and become detectable after removing the modulatory effect conformational modulations occurred during evolution. When the stabilizing effect of the conformational modulator is removed, the suppressed ancestor-like threedimensional structures will be exhibited (Fig. 6b) . This hypothesis may explain the molecular basis of atavism, in which a mutation that causes the loss of evolutionary modulation in a protein would result in the expression of an ancestral trait in contrast to a radical new trait. Although the post-genome-era databases allow extensive sequence analyses for detecting evolutionary relationship of proteins or their functional domains, protein three-dimensional structure analysis has a special value. Ancestral information may be retained in a present-day protein as an ancestor-like alternative conformation that might be more common for one protein than another derived from the same ancestor. Our approach to experimentally detecting evolutionarily suppressed ancestor-like alternative conformations in present-day proteins makes it feasible to dig ''molecular fossils'' to study the origin of present-day protein structures. While the protein threedimensional structure database is rapidly growing, the precise correlation between sequence and folded structure remains to be established. At present, an effective and practical method to compare protein three-dimensional structure differences is extremely valuable for the study of protein evolution. Our data have demonstrated that ancestor-like conformational states can be detected with antibodies against epitopes that represent the ancestor-like alternative conformation. In addition, knowing that an ancestor-like alternative conformation is retained in a protein structure will guide the search for the same information ''hidden'' in the amino acid sequences.
The sensitive and rapid-throughput ELISA epitope analysis (Wang and Jin 1998; Jin et al. 2007 ) can readily detect similarities, differences, and, especially, changes in protein conformation. Although the binary comparisons of epitope affinity titration curves were not able to determine the exact evolutionary distances between protein isoforms, our data demonstrate that this approach is powerful not only in detecting protein allosteric changes during a switch between two active states ) but also in evaluating three-dimensional structure changes on the geological time scale to identify fossils of molecular evolution. Since many mAbs as well as polyclonal antibodies can detect protein conformational changes (Ogut and Jin 1996; Wang and Jin 1998; Jin et al. 2000a Jin et al. , b, 2007 Jin and Root 2000; Biesiadecki et al 2007) , application of this approach can be readily explored in many proteins of interest using existing antibodies.
In addition to strengthening the sequence evidence that TnI and TnT arose from gene duplication, our study provides evidence for the presence of alternative conformational components, or conformers, shared by TnI and TnT, which might have been retained for a functional benefit. It would be interesting to investigate where these components are and the role that they play. For example, the C-terminal domain of TnI is the most conserved region in the TnI polypeptide chain, which undergoes conformational changes in the troponin complex when Ca 2? binds to TnC ). Three-dimensional structure reconstruction studies suggested a possible role for the C-terminal domain of TnI in trapping tropomyosin during myofilament regulation (Pirani et al. 2006) . Since the N-terminal region of TnT may be removed by restricted proteolysis during acute functional adaptation (Zhang et al. 2006; Feng et al. 2008) , the presence and exhibition of a TnI C-terminus-like structure inherited in TnT suggests future investigations of the structural basis of TnI and TnT for their role in the regulation of muscle contraction. Exploring the functional significance of ancestor-like conformational states inherited in present-day proteins will test a novel concept in protein structure-function relationship.
In perspective, our study reports an experimental approach to demonstrate that evolution is data. Investigation of the evolution of protein three-dimensional structures opens the door to the study of molecular paleontology despite the absence of fossil materials. In addition to identifying structural modifications that were critical to the emergence of present-day proteins, understanding this novel mode of evolution and the role of conformational modulator sites that determined the evolutionary divergence of a protein and the consequence of their manipulation will help to predict the structural and functional potentials of the protein and guide the design of structural modifications and the search for effective drug targets. Mutations in such an evolutionary determining structure of a protein might have a high potency to modify phenotypes and cause diseases. The potential of a protein to exhibit suppressed ancestor-like structures suggests the hypothesis that the diverged molecular conformation would be more likely to fall back on an ancestor-like state than to produce a radical new conformation, which calls for further experimental investigation.
